Clinical trials
Active, not recruiting Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| First Hospital of China Medical University | 2 |
| Innovent Biologics (Suzhou) Co. Ltd. | 2 |
| Arnatar Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| Beijing Friendship Hospital | 1 |
| China National Center for Cardiovascular Diseases | 1 |
| Duke Kunshan University | 1 |
| Lin Han | 1 |
| Pulnovo Medical (Wuxi) Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension | 18 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Dyslipidemias | 2 |
| Obesity | 2 |
| Stroke | 2 |
| Atherosclerosis | 1 |
| Atrial Fibrillation | 1 |
| Dementia | 1 |
| Diabetes Mellitus | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.